IMBI
COM:IMBIOPHARMA
iMetabolic Biopharma Corporation
- Privately Held
news impact assignment basic | general | |||||
public peers | general | Nov 12, 2024 10:18 AM | d55fec28 | |||
news daily refresh | general | |||||
news processing daily refresh | general | |||||
news impact assignment daily | general | |||||
news processing basic | general | |||||
company summary | general | |||||
signals | general | Nov 12, 2024 10:18 AM | 5cb73a1b | |||
crunchbase trigger | general | Nov 12, 2024 10:18 AM | e06a543a | |||
crunchbase profile | general | |||||
li profile | general | Nov 12, 2024 10:18 AM | 1f01d0c7 | |||
translate crunchbase fundingrounds | general | |||||
peers | general | Nov 12, 2024 10:18 AM | e92cf679 | |||
news basic | general | Nov 12, 2024 10:18 AM | f9aaa4c2 | |||
bundesanzeiger | filings | |||||
merger acquisitions | company_analysis | |||||
financials download nd | financials | |||||
private financials | financials |
b8e54e30-c9de-4832-8eb4-ce307e8b4ee0